BIS chief Pablo Hernández de Cos said stablecoins lack credibility for payments at scale, while a new FSI study highlights sharp differences in issuer rules.

Latest NewsRead More

You might also be interested in reading Arcutis Biotherapeutics GAAP EPS of -$0.13 beats by $0.02, revenue of $81.5M beats by $7.83M.